Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2003 December;55(4) > Minerva Urologica e Nefrologica 2003 December;55(4):263-75

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,984


eTOC

 

REVIEWS  


Minerva Urologica e Nefrologica 2003 December;55(4):263-75

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: English

External beam radiotherapy as definitive treatment for prostate cancer

Sosa M., Sanguineti G.

Department of Radiation Oncology University of Texas Medical Branch Galveston, TX, USA


PDF  


External beam radiotherapy (EBRT) planning and delivery has dramatically changed in the last 2 decades allowing dose escalation to the prostate while maintaining the same risk of complications.
EBRT plays a major role in the treatment of localized (T1-2) and locally advanced (T3-4) prostate cancer. In this review we will focus on some current issues associated with the “modern” use of EBRT such as what to expect from EBRT in terms of tumor control and side effects, what is the role of biopsy and surgery after EBRT, what is the role of androgen deprivation (AD), and how EBRT compares to brachytherapy.

top of page

Publication History

Cite this article as

Corresponding author e-mail